OPT S.p.A. specializes in consulting, training, and digital services in the public and private healthcare sectors. Net sales break down by activity as follows:definition and implementation of accreditable and certifiable governance models (73.6%);development of digital solutions and patient support programs (11.1%): designed to support care pathways (including online software for managing patients with psoriasis, cancer screening tools, and a web platform for monitoring and managing the nutritional status of cancer patients);organizing scientific events and accredited continuing education programs for healthcare professionals (11%);drafting medical content (4.3%): writing articles, clinical documents, and informational materials in accordance with applicable methodological standards and regulations.
From the exchange listing, not AI-generated.
OPT's offering is currently listed on Euronext Growth. The expected date is Jun 26, 2026. The proposed ticker is OPTS. OPT is headquartered in Italy. It is classified under Health Services.
OPT is expected to list on Jun 26, 2026.
OPT is listing on Euronext Growth.
OPT's proposed ticker is OPTS.
OPT S.p.A. specializes in consulting, training, and digital services in the public and private healthcare sectors. Net sales break down by activity as follows:definition and implementation of accreditable and certifiable governance models (73.6%);development of digital solutions and patient support programs (11.1%): designed to support care pathways (including online software for managing patients with psoriasis, cancer screening tools, and a web platform for monitoring and managing the nutritional status of cancer patients);organizing scientific events and accredited continuing education programs for healthcare professionals (11%);drafting medical content (4.3%): writing articles, clinical documents, and informational materials in accordance with applicable methodological standards and regulations.
Euronext's IPO showcase — a record of companies that have already listed, not an advance-notice feed. Retrieved Aug 3, 2026.
View the original filing on Euronext →Not investment advice. DiscoverIPO is an informational database. Nothing here is a recommendation to buy or sell any security, and no content should be relied on as financial advice. All figures come from public filings and exchange calendars, may be incomplete or out of date, and should be verified against the original source before you act on them.
We use analytics and marketing cookies to understand traffic and improve the site. Cookie Policy